|
Status |
Public on Dec 31, 2010 |
Title |
Allelic status: HCC1395 |
Sample type |
genomic |
|
|
Source name |
DNA from breast cancer cell line
|
Organism |
Homo sapiens |
Characteristics |
cell line: HCC1395 catalog number: ATCC# CRL-2324
|
Treatment protocol |
standard Affymetrix protocol
|
Extracted molecule |
genomic DNA |
Extraction protocol |
standard Affymetrix protocol
|
Label |
standard Affymetrix protocol
|
Label protocol |
standard Affymetrix protocol
|
|
|
Hybridization protocol |
standard Affymetrix protocol
|
Scan protocol |
standard Affymetrix protocol
|
Description |
Data obtained from caBIG (https://cabig.nci.nih.gov) HCC1395
|
Data processing |
Analyzed using dChip with the reference genotypes of sixty individuals obtained from the dChip website
|
|
|
Submission date |
Apr 14, 2010 |
Last update date |
Aug 19, 2016 |
Contact name |
Raj Chari |
E-mail(s) |
rchari@bccrc.ca
|
Organization name |
BC Cancer Research Centre
|
Department |
Cancer Genetics and Developmental Biology
|
Lab |
Wan Lam Lab
|
Street address |
675 West 10th Avenue
|
City |
Vancouver |
State/province |
BC |
ZIP/Postal code |
V5Z 1L3 |
Country |
Canada |
|
|
Platform ID |
GPL3718 |
Series (2) |
GSE21347 |
An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer: allelic status |
GSE21541 |
An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer |
|
Relations |
Reanalyzed by |
GSE85838 |